Jelloul Fatima Zahra, Chen Qiang Hua, Yang Tianyu, Haghi Nina, Brody Judith, Zhang Xinmin, Sheikh-Fayyaz Silvat
1 Hofstra Northwell School of Medicine, Lake Success, NY, USA.
Int J Surg Pathol. 2018 Apr;26(2):135-144. doi: 10.1177/1066896917737161. Epub 2017 Oct 26.
Composite small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) and follicular lymphoma (FL) is extremely rare, and only 13 cases have been reported previously.
We identified 6 cases of composite SLL/CLL and FL in our database and studied their clinical, histologic, immunophenotypic, and cytogenetic features. A literature review of the existing cases was also conducted.
The patients included 4 males and 2 females, with a median age of 72 years. Four patients presented with lymphadenopathy and 2 with extranodal diseases. Lymphocytosis was seen in 2 cases. Serum lactate dehydrogenase levels were within normal range in all but one case. There were 2 histologic patterns: SLL/CLL predominant pattern (type I) and FL predominant or mixed pattern (type II). The type I pattern was exclusively associated with in situ follicular neoplasia (ISFN). The SLL/CLL showed typical morphology and immunophenotype in all the cases. The FL component included low grade (n = 3), ISFN (n = 2), and primary cutaneous FL (n = 1). Four cases had staging bone marrow biopsies including 3 cases with involvement by SLL/CLL and 1 case with involvement by SLL/CLL and FL. Four patients received treatments, one was under clinical surveillance, and one had no available information. All patients were alive after a median follow-up of 22 months.
This is the largest case serial of composite SLL/CLL and FL. The CL affects elderly individuals, presents with advanced clinical stage, and appears to have a relatively indolent clinical course.
复合性小淋巴细胞淋巴瘤/慢性淋巴细胞白血病(SLL/CLL)与滤泡性淋巴瘤(FL)极为罕见,此前仅有13例报道。
我们在数据库中识别出6例复合性SLL/CLL与FL病例,并研究了其临床、组织学、免疫表型及细胞遗传学特征。还对现有病例进行了文献综述。
患者包括4名男性和2名女性,中位年龄为72岁。4例表现为淋巴结病,2例表现为结外疾病。2例出现淋巴细胞增多。除1例血清乳酸脱氢酶水平外,其余均在正常范围内。有2种组织学模式:SLL/CLL为主型(I型)和FL为主型或混合型(II型)。I型仅与原位滤泡性肿瘤(ISFN)相关。所有病例中SLL/CLL均表现出典型的形态和免疫表型。FL成分包括低级别(n = 3)、ISFN(n = 2)和原发性皮肤FL(n = 1)。4例进行了分期骨髓活检,其中3例有SLL/CLL累及,1例有SLL/CLL和FL累及。4例患者接受了治疗,1例接受临床监测,1例无可用信息。中位随访22个月后,所有患者均存活。
这是复合性SLL/CLL与FL最大的病例系列。该疾病累及老年个体,临床分期较晚,临床病程似乎相对惰性。